7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Firre locus produces a trans-acting RNA molecule that functions in hematopoiesis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          RNA has been classically known to play central roles in biology, including maintaining telomeres, protein synthesis, and in sex chromosome compensation. While thousands of long noncoding RNAs (lncRNAs) have been identified, attributing RNA-based roles to lncRNA loci requires assessing whether phenotype(s) could be due to DNA regulatory elements, transcription, or the lncRNA. Here, we use the conserved X chromosome lncRNA locus Firre, as a model to discriminate between DNA- and RNA-mediated effects in vivo. We demonstrate that (i) Firre mutant mice have cell-specific hematopoietic phenotypes, and (ii) upon exposure to lipopolysaccharide, mice overexpressing Firre exhibit increased levels of pro-inflammatory cytokines and impaired survival. (iii) Deletion of Firre does not result in changes in local gene expression, but rather in changes on autosomes that can be rescued by expression of transgenic Firre RNA. Together, our results provide genetic evidence that the Firre locus produces a trans-acting lncRNA that has physiological roles in hematopoiesis.

          Abstract

          LncRNA loci potentially contain multiple modes that can exert function, including DNA regulatory elements. Here, the authors generated genetic models in mice to dissect the role of the syntenically conserved lncRNA Firre in the context of hematopoiesis.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: not found
          • Article: not found

          A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Topological Organization of Multi-chromosomal Regions by Firre

            RNA is known to be an abundant and important structural component of the nuclear matrix, including long noncoding RNAs (lncRNA). Yet the molecular identities, functional roles, and localization dynamics of lncRNAs that influence nuclear architecture remain poorly understood. Here, we describe one lncRNA, Firre, that interacts with the nuclear matrix factor hnRNPU, through a 156 bp repeating sequence and Firre localizes across a ~5 Mb domain on the X-chromosome. We further observed Firre localization across at least five distinct trans-chromosomal loci, which reside in spatial proximity to the Firre genomic locus on the X-chromosome. Both genetic deletion of the Firre locus or knockdown of hnRNPU resulted in loss of co-localization of these trans-chromosomal interacting loci. Thus, our data suggest a model in which lncRNAs such as Firre can interface with and modulate nuclear architecture across chromosomes.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

              Bacterial infection of the mammalian bloodstream can lead to overwhelming sepsis, a potentially fatal syndrome of irreversible cardiovascular collapse (shock) and critical organ failure. Cachectin, also known as tumour necrosis factor, is a macrophage-derived peptide hormone released in response to bacterial lipopolysaccharide, and it has been implicated as a principal mediator of endotoxic shock, although its function in bacterial sepsis is not known. Anaesthetized baboons were passively immunized against endogenous cachectin and subsequently infused with an LD100 dose of live Escherichia coli. Control animals (not immunized against cachectin) developed hypotension followed by lethal renal and pulmonary failure. Neutralizing monoclonal anti-cachectin antibody fragments (F(ab')2) administered to baboons only one hour before bacterial challenge protected against shock, but did not prevent critical organ failure. Complete protection against shock, vital organ dysfunction, persistent stress hormone release and death was conferred by administration of antibodies 2 h before bacterial infusion. These results indicate that cachectin is a mediator of fatal bacteraemic shock, and suggest that antibodies against cachectin offer a potential therapy of life-threatening infection.
                Bookmark

                Author and article information

                Contributors
                john.rinn@colorado.edu
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                13 November 2019
                13 November 2019
                2019
                : 10
                : 5137
                Affiliations
                [1 ]ISNI 000000041936754X, GRID grid.38142.3c, Department of Stem Cell and Regenerative Biology and Harvard Stem Cell Institute, , Harvard University, ; Cambridge, MA USA
                [2 ]ISNI 0000000121885934, GRID grid.5335.0, Department of Medicine, , University of Cambridge School of Clinical Medicine, Addenbrooke’s Hospital, ; Cambridge, UK
                [3 ]ISNI 0000000096214564, GRID grid.266190.a, BioFrontiers Institute, , University of Colorado Boulder, ; Boulder, CO USA
                [4 ]ISNI 0000 0004 0386 9924, GRID grid.32224.35, Department of Molecular Biology, , Massachusetts General Hospital, ; Boston, MA USA
                [5 ]ISNI 000000041936754X, GRID grid.38142.3c, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, ; 77 Louis Pasteur Avenue, Boston, MA USA
                [6 ]ISNI 000000041936754X, GRID grid.38142.3c, Department of Systems Biology, , Harvard Medical School, ; Boston, MA USA
                [7 ]The Jackson Laboratory, JAX Genomic Medicine, Farmington, CT USA
                [8 ]ISNI 0000 0004 1936 8972, GRID grid.25879.31, Department of Pathology and Laboratory Medicine, , Perelman School of Medicine University of Pennsylvania, ; Philadelphia, PA USA
                [9 ]ISNI 0000000419368710, GRID grid.47100.32, Department of Immunobiology and Howard Hughes Medical Institute, , Yale University, School of Medicine, ; New Haven, CT USA
                [10 ]ISNI 000000041936754X, GRID grid.38142.3c, Department of Genetics, , Harvard Medical School, ; Boston, MA USA
                [11 ]ISNI 0000 0001 2167 1581, GRID grid.413575.1, Howard Hughes Medical Institute, ; Boston, MA USA
                [12 ]ISNI 000000041936754X, GRID grid.38142.3c, Joslin Diabetes Center, ; Boston, MA USA
                Author information
                http://orcid.org/0000-0001-5711-9385
                http://orcid.org/0000-0001-8321-6269
                http://orcid.org/0000-0002-2271-945X
                http://orcid.org/0000-0003-4461-0778
                http://orcid.org/0000-0001-7786-8850
                http://orcid.org/0000-0002-7231-7539
                Article
                12970
                10.1038/s41467-019-12970-4
                6853988
                31723143
                b57fd442-08e2-4988-a03b-b908047265f4
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 29 August 2018
                : 3 October 2019
                Funding
                Funded by: FundRef https://doi.org/10.13039/100000057, U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS);
                Award ID: P01GM099117
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s) 2019

                Uncategorized
                stem cells,gene expression,cytokines,lymphopoiesis,long non-coding rnas
                Uncategorized
                stem cells, gene expression, cytokines, lymphopoiesis, long non-coding rnas

                Comments

                Comment on this article